Skip to main content
TipRanks
Go Ultimate75% OFF

Jon Saxe Insider Profile

4 Followers

Jon Saxe, Director at VistaGen Therapeutics, holds 55.75K shares in VistaGen Therapeutics (Ticker: VTGN), holds 177.81K shares in Durect (Ticker: DRRX), holds 105.00K shares in Sciclone Pharmaceuticals (Ticker: SCLN).

Jon Saxe's Trading History

VTGN
VistaGen Therapeutics
Mar 22, 2021DirectorUninformative Buy3.75K$10.04K
DRRX
Durect
Jun 11, 2019―Informative Buy13.61K$339.62K
SCLN
Sciclone Pharmaceuticals
Oct 16, 2017―Uninformative Sell1.51M$1.17M
INSV
Insite Vision
―――$12.84K
PDLI
PDL BioPharma
―――$1.04M

You May Also Like

Jon Saxe insider profile FAQ

What is the percentage of profitable transactions made by Jon Saxe?
The percentage of profitable transactions made by Jon Saxe is 89%.
What is the average return per transaction made by Jon Saxe?
The average return per transaction made by Jon Saxe is 185.40%.
What stocks does Jon Saxe hold?
Jon Saxe holds: VTGN, SCLN, DRRX, PDLI, INSV stocks.
What was Jon Saxe’s latest transaction?
Jon Saxe’s latest transaction was an Uninformative Buy of $3.75K.
What was Jon Saxe's most profitable transaction?
Jon Saxe’s most profitable transaction was an Informative Buy of VTGN stock on August 24, 2020. The return on the trade was 364.00%.
What is Jon Saxe's role in VistaGen Therapeutics?
Jon Saxe's role in VistaGen Therapeutics is Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.

TipRanks measures corporate insiders by the stock transactions they report to the SEC. See how TipRanks ranks experts and calculates performance.